Browse
Log in / Register
Share
On May 7, 2026, Ultraviolette launched the X-47 Venom electric motorcycle from Bengaluru, a model that will carry the company into the next stage of its export strategy. The Venom is an updated version of the X-47 Crossover, and the first 5,000 buyers can book it at Rs 2.6 lakh ex-showroom Bengaluru; the entry price then rises to Rs 3 lakh. The motorcycle is also the first product built on the VX-100 platform, which combines new battery, motor and control systems and will be used for other vehicles in the lineup.
The European rollout begins in November. Ultraviolette will present the Venom at the EICMA motorcycle exhibition in Milan on Nov. 3, and it currently exports to 20 European markets, including Germany, France, Italy and the UK. Europe accounts for about 10% of the company's sales, according to officials. The company wants monthly motorcycle sales to grow from roughly 700 units now to 1,000 units by the first quarter of 2027, with the Venom serving as a lead model.
The technical story behind this launch is as important as the model itself. Rather than building a single-purpose motorcycle, Ultraviolette created the VX-100 as a modular architecture with different battery capacities and power outputs. CEO and co-founder Narayan Subramaniam described it as "a technology foundation for a new generation of products across segments and markets." That language points to a wider plan than one bike, and it explains why the company is investing in a scooter, a second motorcycle, and new production capacity at the same time.
The US entry is in that plan, but details remain unannounced. Ultraviolette has stated that it expects to enter the US in 2027, yet it has not released a target date, model specification, price, or dealer plan. The VX-100 platform makes a US market version technically feasible because battery capacity and power can be tuned for local requirements. Still, a US launch will require homologation, charging compatibility, service infrastructure and local distribution, and none of those decisions are public yet.
The size of the US electric motorcycle segment is different from India's. Established brands and several startups already compete for street and off-road buyers, so a new brand from India would need to find a clear positioning. Ultraviolette's current focus on performance motorcycles could fit with that market, but the company has not said whether the US will receive the Venom, the Shockwave, or another configuration. What is clear is that shared-platform development lowers the cost of adapting a model for the US, which is usually one of the biggest barriers for a smaller overseas manufacturer.
The expansion is not only abroad. Ultraviolette plans to grow its retail network from about 50 locations in India to 100 by the first quarter of 2027. In parallel, it is exploring Latin America and Southeast Asia. The retail plan is also designed to handle a broader product range: the Shockwave motorcycle, the Tesseract scooter, and future VX-100-based vehicles. A larger dealer network gives the company the space to explain multiple products without relying on one model.
Sales targets reflect that wider portfolio. Ultraviolette expects to reach roughly 10,000 vehicles per month by May 2027. That target includes motorcycles and scooters, and it is a significant jump from the current motorcycle run rate. The company is entering the scooter market with the Tesseract, and the Hosur factory is expected to support that move alongside future products. In other words, the 10,000 figure depends on the same infrastructure investment that will serve Europe and the US.
Capital for these plans is already in place. Ultraviolette raised $85 million in September in a round led by Yali Capital and TDK Ventures, with participation from Lip-Bu Tan, who was Intel CEO at the time. The company has said the funds will support manufacturing, new EV platforms and international expansion. The round adds to an investor list that includes TVS Motor, Qualcomm Ventures, Zoho and Lingotto, giving Ultraviolette access to both automotive and technology expertise.
The production side includes a long-term commitment to Tamil Nadu. Ultraviolette is planning to spend Rs 779 crore over five years on a new factory in Hosur, one that is designed to reach an annual capacity of 250,000 vehicles in phases. The plant will handle the Tesseract scooter and future products, while Bengaluru continues to manufacture the existing lineup. Capacity on that scale is hard to justify from India's domestic market alone, reinforcing the point that Europe, the US and other regions are central to the business plan.
The path from the Milan show to US showrooms will not be identical to Europe. European certification standards, charging connectors and market preferences differ from those in the US, but the VX-100 design gives Ultraviolette a single development base to work from. The company did not say whether the Venom sold in Europe would use the same battery and motor calibration as the Indian version, which suggests local tuning is still being finalized.
Founded in 2016 by Narayan Subramaniam and Niraj Rajmohan, Ultraviolette has evolved from a niche performance motorcycle company to a broader EV manufacturer. The Venom's launch on May 7 opens a pipeline that includes the Shockwave and the Tesseract, and the shared VX-100 platform should reduce the cost and complexity of entering new countries. The first test comes in Milan, where European buyers will see the Venom in person, and the next major milestone will be any US-specific announcement ahead of 2027.
